drugset
drugset / Trial / NCT01326611

Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants

NCT01326611 ↗

Phase 4 Completed 273 enrolled Zekai Tahir Burak Women's Health Research and Education Hospital
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of clarithromycin in eradication of ureaplasma urealyticum and prevention of chronic lung disease in premature infants with birthweight \< 1250 g and have ureaplasma urealyticum colonization.

Timeline

Start
2008-05
Primary completion
2010-09
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clarithromycin Small molecule 10 mg/kg Intravenous

Indications

lung disorder